Life Sciences & Healthcare

Deloitte, in collaboration with the APAC CVD Alliance, has released a White Paper that examines HF policies across eight Asia Pacific markets. The findings reveal critical policy gaps and system inefficiencies, while offering a practical roadmap to strengthen HF prevention, care, and long-term management.

This report highlights exponential technology, enhancing efficiency, productivity and patient engagement as the key priorities of health system leaders in 2025.

Despite Industry uncertainties, Life Sciences execs expect their organisations to adapt, grow and generate value

Welcome to the fourth of a Series of Life Sciences and healthcare predictions reports, comprising ten predictions exploring how the world could look in 2030, what it might feel like for different stakeholders in the health ecosystem, the evidence today that informs our views of tomorrow and how AI technologies, specifically GenAI, might help to bring the future closer.

In this report, Project HOPE and Deloitte US have brought together frontline Healthcare workers, programme leaders, health system advisors, policy and advocacy professionals, community leaders and strategic relationships to collaborate on potential solutions for enhancing climate resilience.

Platform businesses are rewiring the traditional value chain. In nearly every industry, well-thought-out platform businesses typically beat traditional businesses because of superior unit economics and network effects.

Deloitte's Electronic Health Record (EHR) solution helps health systems execute Digital Transformation that shifts legacy models into modern best practices anchored on elevating the human experience.

The COVID-19 pandemic exposed a glaring disparity in global vaccine access. The World Economic Forum (WEF) and Deloitte have been collaborating to tackle this challenge by advocating for regionalised vaccine manufacturing ecosystems. This approach aims to revolutionise vaccine production and distribution, promoting equity and resilience in the face of future health crises.

From digital health to biotech and from digital therapeutics to Healthcare IT innovations, there’s a community and a conversation about it at HLTH Europe event.

Measuring the return from pharmaceutical innovation - 14th edition

Deloitte is honoured to be one of a growing list of 60+ signatories of the Zero Health Gaps Pledge, the first global, multi-sector, CEO-level pledge to help advance health equity.

A Deloitte and World Economic Forum report